EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes

Line Davidsen iD, Morten Hasselstrøm Jensen iD, Thomas Kronborg iD, Stine Hangaard iD, Peter Vestergaard, Asbjørn Mohr Drewes, Filip Krag Knop, Simon Lebech Cichosz iD, Søren Schou Olesen

Journal of Diabetes Science and Technology · 2026-11 · 20 (6) · 1878-1887

DOI: 10.1177/19322968251356239 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Diabetes Science and Technology, online erschienen am 18.07.2025. Verfasst von Line Davidsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Pancreatitis, Chronic, Blood Glucose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: A.P. Møller and Chastine Mc-Kinney Møller Foundation, Heinrich Kopp’s Grant, Region North Denmark Health Science Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glycemic variability in diabetes secondary to pancreatic diseases (pancreatic diabetes) remains unclear. We compared glycemic control and variability in patients with pancreatic diabetes and a matched group of individuals with type 2 diabetes using continuous glucose monitoring (CGM).

Methods

We included 30 patients with chronic pancreatitis and insulin-treated secondary diabetes and 30 individuals with insulin-treated type 2 diabetes (matched on HbA1c, age, and sex). Participants wore a blinded CGM for 20±2 days. Glycemic variability was assessed using coefficient of variation (CV), standard deviation (SD), mean amplitude of glycemic excursions (MAGE), and continuous overall net glycemic action (CONGA) at 1 and 2-hour intervals. Glycemic control was evaluated based on time spent in predefined glucose ranges: >250 mg/dL, 181 to 250 mg/dL, 70 to 180 mg/dL (target range), 54 to 69 mg/dL, and 250 mg/dL (8.8% vs 3.1%, P = 0.008), less time in the target range (70-180 mg/dL; 56.7% vs 68.5%, P = 0.044), and more time at 54-69 mg/dL (0.2% vs 0.0%, P = 0.041). Their glycemia risk index for hyperglycemia was also higher (25.5 vs 16.5, P = 0.033).

Conclusion

Patients with pancreatic diabetes have higher glycemic variability than individuals with type 2 diabetes despite comparable levels of HbA1c.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Pancreatitis, ChronicBlood GlucoseHumansFemaleContinuous Glucose MonitoringMiddle AgedMaleGlycated HemoglobinAgedGlycemic ControlAdultInsulinHypoglycemic Agents

Stichwörter der Autor:innen

continuous glucose monitoringglycemic variabilityhypoglycemiapancreatic diabetes

Substanzen

Blood GlucoseGlycated HemoglobinInsulinhemoglobin A1c protein, humanHypoglycemic Agents

Autor:innen und Institutionen

  • Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Clinical Institute, Aalborg University, Aalborg, Denmark.
  • Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
  • Data Science, Novo Nordisk, Søborg, Denmark.
  • Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark.
  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

ORCID-Profile: Line Davidsen, Morten Hasselstrøm Jensen, Thomas Kronborg, Stine Hangaard, Simon Lebech Cichosz

Förderung

  • A.P. Møller and Chastine Mc-Kinney Møller Foundation
  • Heinrich Kopp’s Grant
  • Region North Denmark Health Science Research Foundation
  • Dexcom, Inc
  • Steno Diabetes Center North Denmark

Zitieren

APA

Davidsen, L., Jensen, M. H., Kronborg, T., Hangaard, S., Vestergaard, P., Drewes, A. M., Knop, F. K., Cichosz, S. L., & Olesen, S. S. (2026). Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes. Journal of Diabetes Science and Technology, 20(6), 1878-1887. https://doi.org/10.1177/19322968251356239

Vancouver

Davidsen L, Jensen MH, Kronborg T, Hangaard S, Vestergaard P, Drewes AM, et al. Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes. Journal of Diabetes Science and Technology. 2026;20(6):1878-1887. doi:10.1177/19322968251356239

BibTeX
@article{Davidsen2026,
  author = {Davidsen, Line and Jensen, Morten Hasselstrøm and Kronborg, Thomas and Hangaard, Stine and Vestergaard, Peter and Drewes, Asbjørn Mohr and Knop, Filip Krag and Cichosz, Simon Lebech and Olesen, Søren Schou},
  title = {Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes},
  journal = {Journal of Diabetes Science and Technology},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {1878--1887},
  doi = {10.1177/19322968251356239}
}
Kostenlos starten →